4
Changes in Ownership
COLLEGIUM PHARMACEUTICAL, INC Filed Acc 0001062993-23-003475
President and CEO sold 11,250 shares at $26.88 ($302,400)
- President and CEO gave up 103,857 shares (to pay taxes)
- President and CEO acquired 11,250 shares (option exercise)
- President and CEO acquired 255,194 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Ciaffoni Joseph · President and CEO
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-10 | Grant or award : show line 1 in the form | +117,500 | 366,250 | D | ||
| 2023-02-10 | Grant or award : show line 2 in the form | +137,694 | 503,944 | D | ||
| 2023-02-10 | Shares withheld for taxes : show line 3 in the form | −44,121 | $26.75 | $1,180,237 | 459,823 | D |
| 2023-02-10 | Shares withheld for taxes : show line 4 in the form | −59,736 | $26.75 | $1,597,938 | 400,087 | D |
| 2023-02-13 | Exercise or conversion : show line 5 in the form | +11,250 | $15.90 | $178,875 | 411,337 | D |
| 2023-02-13 | Sale : show line 6 in the form | −11,250 | $26.88 | $302,400 | 400,087 | D |
| Open-market sales · 11,250 sh · avg $26.88 · $302,400 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-13 | Exercise or conversion : show line 7 in the form Stock Option (Right to Purchase) | −11,250 | 0 | D |
Loading xslF345X03/form4.xml…